Resultados de la búsqueda 161-170 of 1283 for Iron overload

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in ...

2. Estar en forma Strength training - Mayo Clinic

3. Enfermedades infecciosas - Ensayos clínicos - Mayo Clinic

   ... toxicity. 2nd arm - An additional group of patients will be enrolled if they previously received FQ antibiotics. appear to be symptomatic and have a ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

6. Hematología - Ensayos clínicos - Mayo Clinic

   ... toxicity. Patient demographics, adverse events, and comorbidities will also be collected via survey and/or medical record review. A selected subset of ...

7. Hematología - Ensayos clínicos - Mayo Clinic

   ... toxicity. Patient demographics, adverse events, and comorbidities will also be collected via survey and/or medical record review. A selected subset of ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The primary endpoint is EFS and 774 eligible and evaluable patients are anticipated to enroll over approximately 5 years. Key secondary endpoints are toxicity, ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...